Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1999
06/09/1999EP0920323A1 Novel use of phospholipids of animal origin in therapy and/or dietetics
06/09/1999EP0920321A1 Vitamine preparations for reducing oxygen consumption during physical efforts
06/09/1999EP0920320A2 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
06/09/1999EP0920319A1 Antagonists of gonadotropin releasing hormone
06/09/1999EP0920318A1 Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
06/09/1999EP0920317A1 Orally applicable formulation of quinolone or naphthyridone carboxylic acids
06/09/1999EP0920316A1 Treatment of psychotic disorders
06/09/1999EP0920315A1 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
06/09/1999EP0920314A1 Non-peptide g-csf mimetics
06/09/1999EP0920313A1 Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
06/09/1999EP0920312A1 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
06/09/1999EP0920311A1 Parenteral paclitaxel in a stable non-toxic formulation
06/09/1999EP0920310A1 Use of aminothiolester derivatives in pharmaceutics
06/09/1999EP0920309A1 Conjugated linoleic acid to maintain or enhance bone mineral content
06/09/1999EP0920308A1 Composition containing calcium, vitamin d and amino acids for treating osteoporosis and promoting bone fracture repair
06/09/1999EP0920306A2 Chemokine receptor antagonists and methods of use therefor
06/09/1999EP0920305A1 Identification of genes altered in multiple myeloma
06/09/1999EP0920300A1 Vegetable oil compositions
06/09/1999EP0920262A1 Nutritional formulations containing water-miscible lipid derivatives as antimicrobial agents
06/09/1999EP0920253A1 Il-8 receptor antagonists
06/09/1999EP0892639A4 Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists
06/09/1999EP0880532A4 Non-nucleotide phosphorous ester oligomers
06/09/1999EP0877563A4 Food and vitamin preparations containing the natural isomer of reduced folates
06/09/1999EP0828482A4 Cosmetic make-up compositions
06/09/1999EP0808157B1 Medicated tissue paper product
06/09/1999EP0799223B1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
06/09/1999EP0799035A4 Emulsion suitable for administering a sphingolipid and use thereof
06/09/1999EP0784613B1 Colchicine derivatives and the therapeutical use thereof
06/09/1999EP0775103B1 Retinoic acid x-receptor ligands
06/09/1999EP0763012B1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors
06/09/1999EP0752981B1 Substituted cyclopentylamine derivatives and their use as calcium channel antagonists
06/09/1999EP0751932B1 Vitamin-d amide derivatives
06/09/1999EP0748321B1 Process for the preparation of an indazole-3-carboxamide derivative
06/09/1999EP0734260B1 Paroxetine tablets and process to prepare them
06/09/1999EP0730598B1 Hindered esters of rapamycin and their use as pharmaceuticals
06/09/1999EP0713390B1 Gelatin capsules containing a highly concentrated acetaminophen solution
06/09/1999EP0666738B1 Inhibitors of farnesyl-protein transferase
06/09/1999EP0647636B1 Benzothiazole compound, process for producing the same, and use thereof
06/09/1999EP0630232B1 Method of treatment for nasal and sinus dysfunction, and horseradish preparation therefor
06/09/1999EP0626963B1 Vinylene-azaindole derivatives and process for their preparation
06/09/1999EP0615549B1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
06/09/1999EP0614456B1 1alpha,24(s)-dihydroxy vitamin d2, its formation and use
06/09/1999EP0589047B1 Method of treating infectious disease, method of preventing putrefaction of cosmetic, and antibacterial/antifungal agent and cosmetic
06/09/1999EP0578723B1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS
06/09/1999CN1219174A Inhibitors of protein farnesyl transferase
06/09/1999CN1219173A Pyrroloazepine compounds
06/09/1999CN1219172A Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
06/09/1999CN1219171A Benzofuran carboxamides and their therapeutic use
06/09/1999CN1219170A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/09/1999CN1219169A Substituted benzylamines and their use for the treatment of depression
06/09/1999CN1219168A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors
06/09/1999CN1219166A Biphenylsulfonamide matrix metalloproteinase inhibitors
06/09/1999CN1219165A Tricyclic compounds having activity specific for integrins, particularly alpha v beta 3 integrins, method for preparing same
06/09/1999CN1219133A Administration of polypeptide growth factors following central nervous system ischemia or trauma
06/09/1999CN1219132A Sustained-release prostaglandin I derivative preparation
06/09/1999CN1219131A Quinoline carboxamides as TNF inhibitors and as PDC-IV inhibitors
06/09/1999CN1219130A Composition comprising a nitrone compound for use in treating ocular inflammation
06/09/1999CN1219129A Use of substituted azaspirane in treatment of asthma
06/09/1999CN1219128A Method of increasing nitric oxide synthesis
06/09/1999CN1219127A Therapeutic anti-asthma agents containing selenium compounds
06/09/1999CN1219125A Intracoronary stents fixing mould containing quinazolinone derivatives
06/09/1999CN1219124A Use of nitrogen-containing complexing agents for deodorization and antimicrobial treatment of skin and textile fibre materials
06/09/1999CN1219104A Method of treating renomous bites and stings
06/09/1999CN1219103A Antibiotic cocktail and method of use
06/09/1999CN1218836A Biological synthetic technology for 1,6-fructose diphosphate
06/09/1999CN1218811A Novel seco compounds from the class of tylosins
06/09/1999CN1218808A Dithio-heterocyclic-pentylene acetamide derivatives
06/09/1999CN1218806A Sorbic acid vitamin C ester
06/09/1999CN1218802A Substituted isoquinoline-3-formamides compounds, its preparing method and its use as medicine
06/09/1999CN1218801A Tri-substituted imidazoles, and process of their preparation and using the same and having their pharmic composition
06/09/1999CN1218797A Process for preparing optical 2-amino-omega-oxo alkane acid derivative
06/09/1999CN1218692A Novel Anti-spasmodic composition and process for manufacture thereof
06/09/1999CN1218680A Liquid for curing scald and burn and its preparing method
06/09/1999CN1218665A High efficiency mifepristone preparation and its preparing method and use
06/09/1999CN1218664A Method for preparing butethanol of injection
06/09/1999CN1218663A Use of 2'-ascorbate phosphate for stabilizing vitamin A and/or vitamin A derivative in cosmetic and modicinal preparation
06/09/1999CN1218661A Cosmetics and medicine containing light stable ultraviolet filter agent
06/09/1999CN1218660A Cosmetics and medicinal preparation containing lightfast ultraviolet filter agent
06/09/1999CN1043576C Pyrido (1,2,3-de) quinoxaline derivatives, process for preparing the same and their use in medicine
06/09/1999CN1043575C Silylated acetylcholinesterase inhibitors
06/09/1999CN1043574C Heterocyclic amines having central nervous system activity
06/08/1999US5910609 Compounds
06/08/1999US5910593 Highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives
06/08/1999US5910592 Substituted thiazolidinedione derivatives
06/08/1999US5910586 Tricyclic aminoalkylcarboxamides; dopamine D3 receptor subtype specific ligands
06/08/1999US5910513 Substituted benzyl derivatives of polyalkylene polyamines and their use in cosmetic and pharmaceutical compositions
06/08/1999US5910512 Capsaicin, magnesium oxide, disodium edta and water; no harsh solvents, gentle to skin; treating rheumatoid arthritis, muscle pain
06/08/1999US5910510 Administering a photoactive absorber, e.g. a porphyrin, and waiting to have it localize in ocular tissue; radiating with laser light; macular degeneration; treating neovascularization
06/08/1999US5910508 Novel compounds useful in modulating cellular hormone receptors; treating skin disorders such as acne, psoriasis
06/08/1999US5910506 Imidazole derivatives as anti-HIV agents
06/08/1999US5910505 Leukotriene antagonists for use in the treatment or inhibition of oral squamous cell carcinoma
06/08/1999US5910504 Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
06/08/1999US5910502 Use of levobupivacaine in paediatric surgery
06/08/1999US5910501 Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolozin-3(4H)-one and related compounds for treating cognitive disorders
06/08/1999US5910499 Leukotriene production inhibiting action and antihistaminic action; oral administration
06/08/1999US5910497 Treating acne vulgaris
06/08/1999US5910495 Use of 1,5-benzo b!1,4-diazepines to control gastric emptying
06/08/1999US5910494 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides
06/08/1999US5910491 Highly lipophilic camptothecin derivatives
06/08/1999US5910490 Inhibition of membrane receptors for elastin which are involved in degradation of fibrous stroma of the connective tissue